|
|
|
40
|
0633X
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
METHOTREXATE
|
UNITREXATE
|
2ML VIAL
|
B
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0633Z
|
ZUVITREX 25MG/ML INJ (ZUV) METHOTREXATE (B)
|
METHOTREXATE
|
ZUVITREX
|
2ML VIAL
|
B
|
5.11
|
5.1104
|
VIAL
|
5
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
20ML VIAL
|
BQ
|
46.43
|
46.43
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
40ML
|
BQ
|
82.12
|
82.12
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
MITOMYCIN
|
ACCORD MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
203.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0671D
|
UNIBLASTIN 10MG INJ (UBI/RXP) VINBLASTINE
|
VINBLASTINE
|
UNIBLASTIN
|
10MG VIAL
|
BQ
|
54.37
|
54.37
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0671F
|
VINBLASTINE 10MG INJ (KWA) (BQ)
|
VINBLASTINE
|
VINBLASTINE
|
10MG VIAL
|
BQ
|
26.94
|
26.9386
|
VIAL
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0681Q
|
UNICRISTINE 1MG INJ (UBI/RXP) VINCRISTINE
|
VINCRISTINE
|
UNICRISTINE
|
1MG VIAL
|
BQ
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0681S
|
BIOCRISTIN INJ (ZYD)
|
VINCRISTINE
|
BIOCRISTIN
|
1ML VIAL
|
BQ
|
13.70
|
13.70
|
VIAL
|
8
|
VIAL
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
06926
|
NEOSTIGMINE 2.5MG/ML INJ (ANT) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
46.21
|
4.6212
|
AMP
|
0
|
BOX
|
ANT
|
CONCORDIA INTERNATIONAL
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
42
|
06928
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
13.18
|
1.32
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
0692H
|
NEOSTIGMINE 2.5MG/ML INJ (SGH/COL)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
17.13
|
1.71
|
INJECTION
|
0
|
AMP
|
SGH
|
SEIGFRIED-HAMELN
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
0692J
|
LASTIGMINE 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE
|
5X1ML
|
BQ
|
16.99
|
3.40
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
40
|
0692L
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X1ML
|
BQ
|
7.83
|
1.57
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
42
|
0692P
|
NEOSTIGMINE 2.5MG/ML INJ (FSB)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X1ML
|
BQ
|
7.80
|
0.78
|
AMPG
|
0
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
Add to Contract
|
IV/IM/SC
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-03-05
|
|
|
|
40
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON/PHA)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
19.14
|
3.83
|
INJECTION
|
0
|
AMP
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
42
|
0694A
|
NEOSTIGMINE 2.5MG/ML INJ (MON)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
5X5ML
|
BQ
|
15.49
|
3.10
|
AMPG
|
0
|
BOX
|
MON
|
MONTAGE PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
101.04
|
10.104
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2024-07-19
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
|
41
|
0694B
|
NEOSTIGMINE 2.5MG/ML INJ (OMG) (BQ)
|
NEOSTIGMINE
|
NEOSTIGMINE
|
10X5ML
|
BQ
|
86.64
|
8.664
|
AMP
|
0
|
BOX
|
OMG
|
OMEGA
|
COL
|
COLLINS LTD
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-20
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-07-19
|
|
|
|
40
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
26.10
|
5.22
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
